SCHEMBL20549571

SCHEMBL20549571

C[C@H](N)[C@@H]1CCN(c2c(F)c(F)c3cc(C(=O)O)c(=O)n4c3c2OC[C@@H]4C)C1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KCNH2 Q12809 8/20 0.50
AADAT Q8N5Z0 2/20 0.43
SCN5A Q14524 2/20 0.41
CYP1A2 P05177 1/20 0.41
CYP3A4 P08684 1/20 0.41
CYP2D6 P10635 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
CACNA1C Q13936 1/20 0.41
KDM4E B2RXH2 4/20 0.40
ALDH1A1 P00352 2/20 0.40
HPGD P15428 2/20 0.40
HSD17B10 Q99714 2/20 0.40
ALB P02768 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
TUBB4A P04350 1/20 0.39
POLB P06746 1/20 0.39
TUBB P07437 1/20 0.39
TUBA3C P0DPH7 1/20 0.39
TUBA1B P68363 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20549572 1.00 KCNH2 (0.50) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549196 0.93 KCNH2 (0.52) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549197 0.93 KCNH2 (0.52) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549480 0.86 KCNH2 (0.58) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549479 0.86 KCNH2 (0.58) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549836 0.86 KCNH2 (0.53) KCNH2AADATSCN5ACYP1A2CYP3A4
SCHEMBL20549840 0.86 KCNH2 (0.53) KCNH2AADATSCN5ACYP1A2CYP3A4
Hydrochloric Acid SCHEMBL20549818 0.83 KCNH2 (0.70) KCNH2AADATSCN5ACYP3A4KDM4E
SCHEMBL20549326 0.82 KCNH2 (0.67) KCNH2AADATSCN5ACYP3A4KDM4E
SCHEMBL20549552 0.82 KCNH2 (0.48) KCNH2AADATSCN5AKDM4EALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20180318311-A1 TRICYCLIC 2-QUINOLINONES AS ANTIBACTERIALS NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH INC. 2018-11-08 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20180318311-A1 TRICYCLIC 2-QUINOLINONES AS ANTIBACTERIALS TOP1, TOP2A, TOP2B KCNH2 2920/4885AADAT 2848/4885SCN5A 1467/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.